A detailed history of Baader Bank Aktiengesellschaft transactions in Moderna, Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 4,134 shares of MRNA stock, worth $271,810. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,134
Previous 3,250 27.2%
Holding current value
$271,810
Previous $346,000 41.62%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$101.21 - $166.61 $89,469 - $147,283
884 Added 27.2%
4,134 $490,000
Q1 2024

May 03, 2024

SELL
$85.37 - $115.44 $97,065 - $131,255
-1,137 Reduced 25.92%
3,250 $346,000
Q4 2023

Feb 08, 2024

SELL
$69.51 - $104.43 $86,470 - $129,910
-1,244 Reduced 22.09%
4,387 $436,000
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $229,552 - $301,458
2,381 Added 73.26%
5,631 $581,000
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $160,567 - $217,518
-1,355 Reduced 29.42%
3,250 $394,000
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $1.01 Million - $1.47 Million
-7,478 Reduced 61.89%
4,605 $707,000
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $1.45 Million - $2.58 Million
-12,270 Reduced 50.38%
12,083 $2.17 Million
Q3 2022

May 04, 2023

BUY
$118.07 - $194.18 $1.45 Million - $2.38 Million
12,270 Added 101.55%
24,353 $2.88 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $21,488 - $35,340
-182 Reduced 0.74%
24,353 $2.88 Million
Q1 2022

May 18, 2022

SELL
$126.46 - $235.05 $268,853 - $499,716
-2,126 Reduced 7.97%
24,535 $4.23 Million
Q4 2021

May 17, 2022

BUY
$225.82 - $368.51 $6.02 Million - $9.82 Million
26,661 New
26,661 $6.77 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.